Hypothalamic Appetite Circuits
The hypothalamic appetite circuits are arcuate nucleus neuron populations that read circulating energy signals and set hunger, satiety and energy expenditure through the melanocortin pathway.
The core of energy homeostasis sits in the arcuate nucleus of the hypothalamus, adjacent to the median eminence where the blood-brain barrier is leaky enough for circulating hormones to reach neurons directly. Two antagonistic populations live there. POMC neurons cleave pro-opiomelanocortin to alpha-MSH, which activates MC4R on second-order neurons in the paraventricular nucleus and suppresses feeding. AgRP and NPY neurons drive feeding and act at the same receptor as an inverse agonist, so the two populations compete for one downstream switch.
The genetics confirm the wiring. Loss-of-function MC4R variants are the commonest monogenic cause of obesity, found in a low single-digit percentage of severe early-onset cases. Setmelanotide, an MC4R agonist approved in 2020, produces weight loss specifically in POMC, PCSK1 and leptin receptor deficiency, upstream lesions that leave the receptor itself intact. Leptin and insulin act on both populations, and GLP-1 receptors sit on POMC neurons and on hindbrain nuclei projecting into the same circuits.
This is why appetite-acting drugs are neurological rather than digestive. Slowed gastric emptying contributes early and wanes, while the central action persists, which is why effects on food intake outlast the gastrointestinal ones. It also explains the asymmetry of weight defence: the circuit responds far more forcefully to an energy deficit than to a surplus.
The circuit is mapped largely in rodents, often with optogenetic tools that have no human equivalent, and firing patterns in a mouse are not a mechanism claim in a person. Marketing that a compound resets the hypothalamus asserts a specific circuit effect that essentially no research peptide has shown in humans, and reduced food intake alone does not identify where in the pathway anything acted.